Liu Q, Zeng H, Wu X, Yang X, Wang G. Global Prevalence and Hemagglutinin Evolution of H7N9 Avian Influenza Viruses from 2013 to 2022. Viruses. 2023 Nov 4;15(11):2214
H7N9 avian influenza viruses have caused severe harm to the global aquaculture industry and human health. For further understanding of the characteristics of prevalence and hemagglutinin evolution of H7N9 avian influenza viruses, we generated the global epidemic map of H7N9 viruses from 2013 to 2022, constructed a phylogenetic tree, predicted the glycosylation sites and compared the selection pressure of the hemagglutinin. The results showed that although H7N9 avian influenza appeared sporadically in other regions worldwide, China had concentrated outbreaks from 2013 to 2017. The hemagglutinin genes were classified into six distinct lineages: A, B, C, D, E and F. After 2019, H7N9 viruses from the lineages B, E and F persisted, with the lineage B being the dominant. The hemagglutinin of highly pathogenic viruses in the B lineage has an additional predicted glycosylation site, which may account for their persistent pandemic, and is under more positive selection pressure. The most recent ancestor of the H7N9 avian influenza viruses originated in September 1991. The continuous evolution of hemagglutinin has led to an increase in virus pathogenicity in both poultry and humans, and sustained human-to-human transmission. This study provides a theoretical basis for better prediction and control of H7N9 avian influenza.
See Also:
Latest articles in those days:
- Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses 6 hours ago
- Dynamic ensemble deep learning with multi-source data for robust influenza forecasting in Yangzhou 6 hours ago
- Structural and immunological characterization of the H3 influenza hemagglutinin during antigenic drift 6 hours ago
- Novel Highly Pathogenic Avian Influenza A(H5N1) Virus, Argentina, 2025 9 hours ago
- Avian influenza overview September - November 2025 1 days ago
[Go Top] [Close Window]


